How important is a severely diminished diffusion capacity in determining whether to offer a lung cancer patient radiotherapy?  

Does it factor into your decision making in the setting of restricted spirometry and normal lung volumes? Does this differ for SBRT v. chemoRT?



Answer from: Radiation Oncologist at Academic Institution